SAN DIEGO, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Woman Care Global (WCG) has announced that it will market the Gynocular™, through a distribution agreement with Swedish-based manufacturer Gynius.
The Gynocular was developed to make a gold standard cervical examination convenient and accessible to every health setting in the world. The Gynocular has cutting edge optics and LED Technology. It is lightweight and easily fits into a pocket or a small bag, making the Gynocular the world's first truly portable colposcope. The Gynocular is FDA approved and CE-marked.
WCG will handle all product registration and commercialization of the Gynocular in various markets in Africa, Latin America and Asia and will also be distributing the product in the United States.
"We are completely aligned with Gynius in our shared mission to improve women's health throughout the world," said Kelly Culwell, MD, MPH, WCG's Chief Medical Officer. "The Gynocular is an easy-to-use portable technology that enables broader access to colposcopy. This is a win-win for both healthcare providers and the women they serve."
About WomanCare Global
Woman Care Global is a global non-profit healthcare company whose mission is to provide reproductive health solutions for women and girls around the world. Leveraging our medical, social and commercial expertise, we have built a sustainable value chain that enables us to reliably deliver high-quality products and point of care services, resulting in more informed providers and more family planning options for women and girls. Our hybrid model redirects financial surplus achieved from sales in developed countries to under-served markets thereby eliminating economic and geographic barriers and increasing impact. For more information, please visit womancareglobal.org.